Table 1.
Product | MOA | License Holder(s) | Phase of Development |
---|---|---|---|
Tenofovir gel | NRTI | CONRAD and IPM | Phase IIB |
Dapivirine gel and ring | NNRTI | IPM | Phase I/II |
Dapivirine-maraviroc combination gel and ring | NNRTI + CCR5 blocker | IPM | Phase I planned |
Maraviroc ring and gel | CCR5 blocker | IPM | Phase I planned |
Maraviroc-tenofovir combination film | CCR5 blocker + NRTI | IPM | Late preclinical |
MIY-150 gel and ring | NNRTI | Population Council | Late preclinical |